Faculty Publications
GOG0182-ICON5: 5-arm phase III randomized trial of paclitaxel (P) and carboplatin (C) vs combinations with gemcitabine (G), PEG-lipososomal doxorubicin (D), or topotecan (T) in patients (pts) with advanced-stage epithelial ovarian (EOC) or primary peritoneal (PPC) carcinoma.
GOG0182-ICON5: 5-arm phase III randomized trial of paclitaxel (P) and carboplatin (C) vs combinations with gemcitabine (G), PEG-lipososomal doxorubicin (D), or topotecan (T) in patients (pts) with advanced-stage epithelial ovarian (EOC) or primary peritoneal (PPC) carcinoma.
J Clin Oncol. 2006 Jun;24(18):256S-256S.
Abstract SO JOURNAL OF CLINICAL ONCOLOGY LA English DT Meeting Abstract C1 Gynecol Oncol Grp, Gynecol Canc Intergrp, Philadelphia, PA USA. Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
Last updated on Saturday, March 13, 2010